leisure time -WSS

leisure time

author：leisure time 2025-10-02 17:56:26 - browse：2

Terry Horgan pictured at home -- coverage from STAT — Terry Horgan in his family's Montour Falls, N.Y., home, in an undated photo. Kate Collins/The Journal via AP

Last October, a 27-year-old man with Duchenne muscular dystrophy died after receiving a CRISPR-based treatment custom built to treat his particular genetic mutation.

Results of a detailed investigation released on Wednesday suggest that the patient, Terry Horgan, likely died of a previously undocumented adverse effect of the virus used to deliver the CRISPR machinery to his cells.

These viruses, known as adeno-associated viruses, or AAVs, are used in several approved drugs and hundreds of clinical trials to deliver genes into patients, because they are generally benign. But at high doses they can cause side effects and, occasionally, deaths through one of several mechanisms, such as directly injuring the liver or triggering a type of immune response known as complement activation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Eliminate the waiting period for sterilization covered by Medicaid

WSS

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

For Medicare Advantage, Democrats want stronger protections around AI

Oprah kicked off a national conversation on obesity. Let's have it

Senators start work on Medicare physician payment reform

Gilead might be held responsible for not developing a drug

Readout Newsletter: Merck, Vertex, and Viking updates

entertainment

leisure time

knowledge

Drug repurposing or repositioning? The language matters

Scientists boost immune system in aging mice by making it youthful

Walensky prepares to leave CDC — and Congress — behind

Supreme Court mifepristone arguments center on docs' right to sue

23andMe had bad news about my health. I wish a person had delivered it

Medicare Advantage proposed rates disappoint insurers

Apple is now the first public company to be valued at $3 trillion

Medicare Advantage proposed rates disappoint insurers

United colonoscopy coverage change 'may cost lives,' doctors say

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

Wikipedia

Readout LOUD podcast: mifepristone case, GLP

What should King Charles tell the public about his cancer?

Why the world’s most expensive drug might be worth the price

Biden report: The neurospychology of memory and aging

Readout LOUD podcast: mifepristone case, GLP

BioAge raises $170M for combination therapy with Zepbound

focus

entertainment

explore

knowledge